The development of new child mental health quality measures poses methodological challenges that will require a paradigm shift to align research with its accelerated pace.
Recent health policies have accelerated the development and use of quality measures for children receiving publicly-funded care. 1, 2 In response, a legislatively mandated national committee and a non-profit organization systematically rated large pools of quality measures and recommended a limited number to monitor the quality of care received by U.S. children. Although these initiatives were independent and used different approaches to select and rate child health care quality measures, each recommended few measures related to child mental health care. 3, 4 This gap is of public health significance because improving the quality of child mental health care is a longstanding national priority 5-9 and there is substantial room for improvement in mental health care for both private and publicly-insured populations. [10] [11] [12] [13] [14] [15] [16] [17] [18] This paper reviews: CHIPRA also funded 10 five-year demonstration projects to states at an estimated total cost of $100 million on February 2010, of which seven propose to develop, test, evaluate and/or report adherence to quality measures. 20 Outreach and technical assistance efforts to the states to report on adherence to 12 of the 24 measures in the initial core set began in 2011. 21 The use of the measures is likely to be sustained through financial incentives to collect and report on adherence rates on quality indicators through a matching Federal
Medical Assistance Percentage that is part of the American Recovery and Reinvestment
Act of 2009 (ARRA). 22 Eligible providers will receive these payments for demonstrating "meaningful use" of quality measures under the Electronic Health Records Incentive
Program and are anticipated to be given the capacity to benchmark their own performance against aggregated data. 22 Together, these activities are envisioned to be "the first steps taken" to reach the goal of a quality-driven, evidence-based national system of child health care. 21 Consistent with this vision, the National Quality Strategy (NQS) was established "to improve the delivery of health care, services, patient health outcomes, and population health" for all Americans, as part of the 2010 Patient Protection and Affordable Care Act (ACA). 2, 23, 24 This is the first legislation to set national goals to improve the quality of health care in public and private health care programs. It will guide all US Department of Health and Human Service quality improvement programs and regulations, and set criteria to measure the quality of health care to align with national efforts for quality improvement. 24 The three aims of the NQS are to improve the overall quality of care, improve the health of the U.S. population, and reduce the cost of quality health care.{#23} To adapt the NQS for behavioral health care, the Substance Abuse and Mental
Health Services Administration (SAMHSA) developed the Behavioral Health Quality
Framework that tailors the six national priority areas to behavioral health care, reinforcing how the three aims of the NQS could be equally applied to the care of mental health problems. 3 Contemporaneously, the National Quality Forum (NQF) is a private, non-profit organization that was given federal funding to conduct a parallel effort to identify and endorse measures that could be used to assess the quality of children's healthcare. The NQF is dedicated to improving the quality of American health care by: 1) building consensus on national priorities and goals for performance improvement and working in partnership to achieve them; 2) endorsing national consensus standards for measuring and publicly reporting on performance; and 3) promoting the attainment of national goals through education and outreach programs. 25 As part of their mission, the NQF organized a standardized process to evaluate and endorse voluntary consensus standards for patient outcomes for child health and mental health, and child health candidate standards. The projects were undertaken between 2009-2011 and known as the Patient Outcomes (Phase III): Child Health and Child Health Measures Projects. While specific approaches across these different national initiatives varied, they raised similar questions about how to address barriers that limit the feasibility of these quality measures, the acceptable threshold for sufficient scientific evidence for clinical validity, and how to address methodological limitations that could influence the interpretation of findings.
Quality Measure Selection Process

CHIPRA: Development of Initial Core Set of Measures
In partnership with AHRQ and CMS, the initial core measure set was identified using an evidence-informed process that integrated input from a broad array of stakeholders and public comments. 26 A multidisciplinary AHRQ National Advisory
Council Subcommittee on Children's Healthcare Quality Measures for Medicaid and Children's Health Insurance Programs (SNAC) was formed in May 2009. The SNAC was charged with establishing quality measure evaluation criteria, identifying a strategy for gathering measures, and applying the evaluation criteria to the measures. 26 It was comprised of multiple stakeholders, including officials from publicly-insured programs, national professional organizations, and child and family advocacy organizations as well as national experts in health care quality measurement.
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Over a four-month period, the SNAC held two public meetings and undertook substantial work outside of these meetings. This work included assessing an initial set of quality measures in use by Medicaid and CHIP programs using an adapted version of the RAND/UCLA modified Delphi method, identifying a process to supplement these measures through a public call for nominations, and subsequently assessing the nominated measures using the same modified Delphi method. The RAND/UCLA appropriateness method is a well-established approach that integrates scientific evidence with expert clinical judgment 27 and that has been successfully used to assess the quality of outpatient general health care among children nationally. 28 It has also been used to assess the quality of mental health care statewide among children receiving publiclyfunded outpatient specialty mental health care. 18 The process integrates a review of the evidence-base for a proposed measure, and two rounds of structured expert ratings.
During this process, the SNAC assessed the validity, feasibility, and importance of 119 measures, of which 12 were specific to child mental health. For each measure, the SNAC rated the level of scientific evidence supporting the measure, feasibility of implementing the measure, and the measure's importance. When considering importance, highest priority was given to measures that were deemed actionable (by which the SNAC meant the extent to which a publicly insured program would likely be able to improve their performance) and likely to substantially reduce health care costs. open to the public, member voting was done openly, information about the meeting was posted on the NQF website, and time for public comment was allocated on the agenda.
The measures were rated on four main criteria: 1) importance to measure and report the nominal topic; 2) scientific acceptability; 3) usability; and 4) feasibility. Within these four domains, the reviewer also rated subdomains to standardize the rationale for the main criterion rating. If the measure was deemed not to be important, the rating stopped. The extent a measure met the remaining criteria was rated on a four-point scale (i.e., completely, partially, minimally, or not at all). During the vote for recommendation for endorsement, each reviewer personally weighed his or her item ratings.
Recommendations were then classified as with or without consensus by NQF staff.
Details of the rating criteria used for both initiatives are summarized in Table 1 . The NQF criteria are regularly updated, and more rigorous criteria for scientific acceptability are being applied for the 2012 Behavioral Health Measures Evaluation.
INSERT TABLE 1 HERE
Recommended or Endorsed Quality Measures for Child Mental Health Care
Although the approaches varied, both processes yielded relatively few child mental health quality measures (Table 2) . Of the 70 measures considered for the CHIPRA Initial Core Set, 12 pertained to child mental health care and of these, 3 were recommended. Of the 101 candidate measures reviewed during the NQF projects, 15
pertained to child mental health care. Five of these overlapped with the three CHIPRA measures, two were the same measure for two different age groups of teens, and one measured maternal mental health. Thus there were nine unique measures of the quality of child mental health care in CHIPRA and NQF combined.
For both initiatives, priority was placed on the development of a balanced set of measures to build capacity to track a wide breadth of quality care. For these measures, the age ranges varied in the specifications, such that one was restricted to children aged 0-5, two to ages 13-18 and six included all or most child age groups. The focus of concern also ranged from specific to general problem areas. Two measures focused on depression, two on attention-deficit/hyperactivity disorder, one on risky behaviors, one on suicidality, and three on general problem areas. Two of the measures involved monitoring, three called for screening, and four required clinicians to make assessments.
Evidence Strength for Child Mental Health Care Quality Measures
One potential next step for the creation of quality standards is to rate the empirical evidence that supports each measure. The Oxford Centre for Evidence-Based Medicine (CEBM) 40 has put together detailed methods for conducting these kinds of ratings and all of the CHIPRA measures were reviewed according to the CEBM standards. 26 The As noted above, the quality of the evidence for the three CHIPRA measures had been graded according to CEBM standards. Although one of the CHIPRA measures received the low grade of 'D', two measures were graded as 'B', but even these measures were noted to have limitations in the quality of their evidence. One measure had been assessed in studies that did not specify age ('CHIPRA #21: "Follow up after hospitalization for mental illness') and the other revealed 'no data on whether screening using standardized tools ultimately leads to better outcomes for these children' (CHIPRA #8; 'Screening using standardized screening tools for potential delays in social and emotional development').
Although NQF did not utilize CEBM standards, there was a section on evidence and all relevant studies on the NQF website for each measure. 25 For the purposes of this paper we reviewed the studies cited there and supplemented this with a review of studies on the website of the steward listed for each measure. We also conducted a search using
Ovid and PubMed studies published from 2001 to 2011 using the six measure names as specific and general search terms.
For only two of the measures did we find studies suggesting higher than a 'D' level of evidence: the NQF summary for "Depression Screening by 13/18 years of age"
(NQF # 1394 & 1515) noted that this measure had been rated by the United States
Preventive Services Task Force as having a B level of evidence, citing studies 41, 42 that reported that screening instruments both performed well and increased the use of effective treatments; and that use of the 'Pediatric Symptom Checklist was associated with increased rates of referral and improved functioning for children after intervention. [43] [44] [45] [46] [47] [48] Overall, the evidence strength supporting the child mental health quality measures was variable. None of the measures were supported by research using randomized clinical trials to examine the relationship between adherence and outcomes that were meaningful to "decision makers" (i.e., parents, providers, payers) 49 or impact on health. 50 Such a research gap is consistent with adult mental health and substance abuse care quality measures. effective diagnosis, follow-up, and treatment for pediatric patients, ages 4 to 18 years, after a diagnosis of ADHD has been made. Following development and specification of pediatric quality measures for ADHD, these measures will be tested for: 1) performance of the measure (using) manual chart review; 2) feasibility and validity of using the Electronic Health Record to calculate the measure; and 3) the feasibility of specifying the measures for construction using administrative data sources and the reliability of the resulting measure output.
Major Depression
The NCINQ is taking the lead on the development and refinement of quality measures related to adolescent depression. Major depressive disorder (MDD) is a disabling condition that is associated with long-term complications and may lead to suicide. 42 Based on a review of all major guidelines, evidence reviews, and advice from family partners, clinicians and researchers NCQA has developed a logic model for adolescent depression management and follow-up. This model addresses several key aspects of management including: 1) screening and assessment; 2) treatment options and initiation of treatment; and 3) symptom monitoring, treatment course and remission. The logic model uses a "measurement-based care" approach to conceptualize the steps involved in optimizing care. 61 For depression management, measurement-based care starts with use of standardized tools to screen for depression in primary care, followed by confirmatory assessment and monitoring of symptom and functioning throughout the episode of depression to guide treatment decisions and to assess response and remission.
The model also acknowledges that successful implementation depends on adequate readiness of primary and specialty providers. NCINQ stakeholder panels provided feedback both on the overall approach and to identify the most salient opportunities where quality measures are likely to improve quality and outcomes.
Identifying Eligible Populations for Mental Health Quality Measurement
The COE4CCN is working to develop several measures intended to advance quality measurement in the area of general child mental health care. One of the Center's early efforts has focused on ways of coding the presence of mental health conditions based on diagnostic codes available in administrative data. Use of these codes to identify children with mental health problems will go through a process of validation using abstracted medical record data as the gold standard. If the methodology developed is found to be valid, it will then be further tested and refined using existing, large datasets like Medicaid claims from entire states. These analyses are being carried out using data from one state Medicaid agency as well as a large urban tertiary care children's hospital.
Through this approach, the COE4CCN is working to build capacity to use existing data infrastructure to identify children with mental health conditions, describe the services delivered and explore new approaches to link measure adherence with clinical outcomes. The long-accepted observation that mental health problems are underrecognized in pediatrics 62 suggests that the prevalence of child mental health problems may be underestimated. Delivery of mental health care may also be under-reported because procedure codes for evidence based mental health care are often missing in Medicaid claims data. 17, 18 Nevertheless, this new direction has the potential to bring a kind of 'parity' with physically based medical diagnoses in the identification of mental health problems. Secondly, an algorithm to identify children with "social complexity"
using Medicaid claims and enrollment data is under development. For the purposes of this project, social complexity is defined as the presence of one or more social risk factors hypothesized to be strong correlates of mental health. Valid identification of social complexity may enhance the identification of mental health problems that may be underreported as diagnoses in Medicaid service encounter data, stand in as a proxy, or serve as a marker for children at risk for mental health problems who might benefit from early preventive interventions. Data sources will include Medicaid claims and encounter data from one state and surveys from parents and health care providers.
Early Lessons Learned
The inclusion of quality measures related to child mental health care and recent priority placed on developing new ones are major advances that are consistent with the recommended trajectory of integrating mental health care into the patient-centered medical home. 63 The provider levels, must be addressed to enhance the capacity to capture data that links measure adherence to improved care and meaningful outcomes. Generating these desired data however demands time; therefore, priority must also be placed on reducing provider and parent burden. Further, new research models that promote engagement of community clinicians may require adaptation to test the clinical validity of child mental health quality measures. 64 To continue to strive to find a "common ground", a new partnered research paradigm for quality measurement for children is needed to capitalize on the rich network of collaboration from CHIPRA, NQF and other related projects. Early dialogue and sustained communication channels for information exchange, funding that cuts across these facets, and continuing to search for common goals aimed at improving the outcomes of children can serve as a starting point to address this important challenge.
The adoption of electronic health care records may also serve as an additional mechanism to further strengthen these collaborations through active engagement in their development and implementation. Together, these activities share the original vision of a qualitydriven health care system for children which can only truly improve through a continuous process of quality improvement conducted in full partnership. 
10.
Bethell CD, Kogan MD, Strickland BB, Schor EL, Robertson J, Newacheck PW.
A national and state profile of leading health problems and health care quality for US children: key insurance disparities and across-state variations. Acad Pediatr.
2011;11(3 Suppl):S22-S33. • The measure should be actionable.
State Medicaid and CHIP programs, managed care plan, and relevant health care organizations should have the ability to improve their performance on the measure with implementation of quality improvement efforts.
• The cost to the nation for the area of care addressed by the measure should be substantial.
• Health care systems should clearly be accountable for the quality problem assessed by the measure
• The extent of the quality problem addressed by the measure should be substantial (i.e., significant proportion of the US child population should be affected by poor performance on the measure).
• There should be documented variation in performance on the measure.
• The measure should be representative of a class of quality problems (i.e.., a "sentinel measure" of quality of care provided for preventive care, mental health care, or dental care, etc.).
• The measure should assess an aspect of health care where there are known disparities.
• The measure should contribute to a final core set that represents a balance portfolio of measures and is consistent with the intent of the legislation.
Importance to measure and report: the extent to which the specific measure focus is important to making significant gains in health care quality (safety, timeliness, effectiveness, efficiency, equity, patient-centeredness) and improving health outcomes for a specific high impact aspect of healthcare where there is variation in or overall poor performance.
• High impact
• Opportunities for improvement
• Outcome or evidence to support measure focus
• Improving performance on measures included in the core set should have the potential to transform care for our nation's children.
Scientific Acceptability b
Validity: the degree to which a quality measure is associated with what it purports to measure.
• It meets criteria for scientific soundness, defined as adequate scientific evidence or, where evidence is insufficient, expert professional consensus to support the relationship between structure and process, structure and outcome, or process and outcome.
• The measure itself is valid-that is, it should truly assess what it purports to measure.
Scientific acceptability of measure properties
• Precisely specified
• Reliability testing
• Validity testing
• Exclusions justified
• Risk adjustment for outcomes/resource use measures
• Identification of meaningful difference in performance
• Comparability of multiple data sources/methods
• Disparities in care Feasibility c Feasibility: the degree to which the measure is free from random error
• The data necessary to score the measure are available to state Medicaid and CHIP programs.
• Detailed specifications are available for the measure
• Estimates of adherence to the measure based on available data sources are likely to be reliable and unbiased. This
• allows for meaningful comparisons across states, programs, individual Feasibility: the extent to which the required data are readily available, retrievable without undue burden, and can be implemented for performance measurement.
a CHIPRA Rating: 7-9= definitely important and meets several of the criteria, 4-2= uncertain level of importance and meets some of the criteria but fails to meet some of the criteria given higher weight (1-4), 1-3=fails to meet most of the criteria; CHIPRA Median Pass Score: ≥4; NQF Rating: Yes/No (must pass). b CHIPRA Rating: 7-9=scientifically sound and the measure itself is definitely valid (i.e., sufficient evidence), 4-2=uncertain scientific soundness (i.e., insufficient evidence) and the measure itself has uncertain validity, providers or institutional providers.
Usability d
Usability: the extent to which intended audiences (e.g., consumers, purchasers, providers, policy makers) can understand the results of the measure and are likely to find them useful for decision making.
• Meaningful, understandable and useful information
• Relation to other NQF-endorsed measures (harmonization, distinctive or additive value
• Data generated as a byproduct of care processes
• Electronic sources
• Exclusions
• Susceptibility to inaccuracies, errors, or unintended consequences
• Data collection strategy/implementation The types and rigor of studies at various levels of evidence depend on the study purposes (e.g., therapy/prevention, prognosis, diagnosis, differential diagnosis/symptom prevalence; economic and decision analyses). Most of the studies submitted or identified as documentation of underlying scientific soundness for the measures were therapy or prevention studies. For those studies, Level 1 studies are systematic reviews of randomized controlled trials (RCTs). Level 2 studies include systematic reviews of cohort studies, individual cohort studies, including low-quality RCTs), and "outcomes" research. Level 3 studies are systematic reviews with homogeneity of case-control studies or an individual case-control study. Level 4 studies are case-series and poor quality cohort and case-control studies. Level 5 evidence is defined as expert opinion without explicit critical appraisal, or based on physiology, bench research or "first principles." NR = Not rated as to grade of evidence
